Form 8-K - Current report:
SEC Accession No. 0001851734-22-000600
Filing Date
2022-10-11
Accepted
2022-10-11 16:05:28
Documents
18
Period of Report
2022-10-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cdxc20221007_8k.htm   iXBRL 8-K 37941
2 EXHIBIT 5.1 ex_430255.htm EX-5.1 8290
3 EXHIBIT 10.1 ex_430251.htm EX-10.1 158597
4 EXHIBIT 99.1 ex_430257.htm EX-99.1 17160
9 cooley.jpg GRAPHIC 9877
10 ex_430257img001.jpg GRAPHIC 3293
  Complete submission text file 0001851734-22-000600.txt   419676

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cdxc-20221010.xsd EX-101.SCH 3602
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cdxc-20221010_def.xml EX-101.DEF 11533
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cdxc-20221010_lab.xml EX-101.LAB 15415
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cdxc-20221010_pre.xml EX-101.PRE 11689
12 EXTRACTED XBRL INSTANCE DOCUMENT cdxc20221007_8k_htm.xml XML 2592
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37752 | Film No.: 221304100
SIC: 2833 Medicinal Chemicals & Botanical Products